Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.4500
+0.0500 (12.50%)
Dec 12, 2025, 9:30 AM EST
Cell Source Market Cap
Cell Source has a market cap or net worth of $18.02 million as of December 15, 2025. Its market cap has decreased by -2.36% in one year.
Market Cap
18.02M
Enterprise Value
28.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.45
Market Cap Chart
Since July 1, 2014, Cell Source's market cap has decreased from 36.03M to 18.02M, a decrease of -49.99%. That is a compound annual growth rate of -5.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 21.97M | 43.96% |
| Dec 31, 2024 | 15.26M | -14.98% |
| Dec 27, 2023 | 17.95M | -40.09% |
| Dec 29, 2022 | 29.96M | -30.67% |
| Dec 31, 2021 | 43.22M | -32.39% |
| Dec 31, 2020 | 63.92M | 119.45% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |